
#PATIENT LISTENER ●Physician Researcher ●Biopharmaceutical R&D Executive and Board Director ●RT≠endorse OwnViews
New York, USA
Joined June 2015
- Tweets1.8K
- Following492
- Followers1.8K
- Likes1.2K
Amrit Ray retweeted
2/4 The film showcases experts (below) across the #clinicaltrials ecosystem, offering valuable insights on the significance of good trials, their core attributes & how they can be improved.
#EmerCooke @MartinLandray @DrAmritRay #IanHudson @LevertyRenee #FredoniaWilliams
Amrit Ray retweeted
We're excited to launch our new content series #GoodTrialsGrapevine in honor of #CTD2023, showcasing expert insights on key themes in clinical research; what makes a good trial & why.
Kicking off the series with a quote from healthcare veteran & business leader @DrAmritRay! 👇
Kudos to the team @FondationIpsen - for terrific work: Can alternative funding mechanisms help R&D and access for #Rarediseases ? linkedin.com/posts/amrit-ray…
Amrit Ray retweeted
Our #webinar "Humanizing the support of patients living with a #RareDisease" is vailable now on demand or as a #podcast. FREE. @DrAmritRay @kathleen_bogart and @alannakyee. fondation-ipsen.org/webinar/…
Amrit Ray retweeted
Deeply moving and informative #scienceWebinar about "The profoundly personal side of #rareDisease: Humanizing the therapeutic journey of patients" with the panelists .@kathleen_bogart, .@alannakyee, and .@DrAmritRay.
Huge thanks for sharing your experiences.💙
#advocacy
Next week, join #ScienceWebinars for our last #ScienceAndLife webinar of the year on rare diseases:
The profoundly personal side of rare disease: Humanizing the therapeutic journey of patients
Thursday, 10 November 12 noon ET
Register today at fal.cn/3tgdT
Amrit Ray retweeted
Join #ScienceWebinars for their last #ScienceAndLife webinar of the year on #RareDiseases:
The profoundly personal side of rare disease: Humanizing the therapeutic journey of patients
On Thursday, 10 November, 12 p.m. ET
Register today at scim.ag/r0
#Webinar
Amrit Ray retweeted
Great to see this timely new book on '#RealWorldEvidence in a Patient-Centric Digital Era' edited by @kel_zou, Lobna Salem, and @DrAmritRay now published by @CRC_MathStats. routledge.com/Real-World-Evi… @ViatrisInc #pharma #outcomes #DataScience
Join us at next week’s Congressional Caucus on Rare Diseases @RareAdvocates. Looking forward to inspiring keynotes from @RepGusBilirakis & @amyklobuchar and an incredible panel of speakers! @EveryLifeOrg #everyvoicematters linkedin.com/posts/amrit-ray…
Amrit Ray retweeted
Did you know that 70% of all deaths are due to noncommunicable diseases?
This Global Week for Action on #NCDs it's time to wake up and #ActOnNCDs
In this video @WHO Director-General @DrTedros explains how together we can #beatNCDs
📽️➡️ youtu.be/bFeiiPlnXhw
Amrit Ray retweeted
Don’t forget the pandemic of silent killers in the midst of the Covid-19 crisis #NCDs The emerging markets will bear a disproportionate burden unless they act now! #healthcare @DrKannanSydney @DrAmritRay thestar.com.my/opinion/lette…
Amrit Ray retweeted
Upjohn, a division of Pfizer, is proud to partner with @ACCinTouch on this new #NCDAcademy initiative, bringing CVD and stroke prevention training to healthcare professionals around the world.
The #NCDAcademy course in #CVD & #Stroke Prevention is available! Primary care providers who complete all lessons and pass the final exam can unlock a digital badge to showcase their mastery of this topic on social & professional networking sites. More: https://teapawt.net/t.co/ItmDRQiAqp
Amrit Ray retweeted
How do we tip the scales in the noncommunicable disease crisis? Upjohn, a division of Pfizer, is using an evidence-based approach to develop tailored solutions by market. Read more on reducing the risks of #NCDs: https://teapawt.net/t.co/fFUcmV1EAE
Amrit Ray retweeted
#BioAsia2020 is gearing up! We are looking forward to having @DrAmritRay, Global President R&D & Medical, @pfizer with us. Join us as he speaks about global healthcare scenario with a focus on non-communicable diseases' increasing burden in India.
#TodayForTomorrow #AmritRay
Amrit Ray retweeted
Catch these trailblazers at #BioAsia2020
@carlhjune @kiranshaw @VasNarasimhan #PaulStoffels #PeterPiot @DrAmritRay and many more!
Feb 17-19 #Hyderabad Miss this at your own risk! Register now: https://teapawt.net/t.co/4RNPSt07o2
"Advancing Healthcare through Collaborative Science - Upjohn and NYUAD launch a new center for Real World Data" linkedin.com/pulse/advancing… #enoughNCDs #partnership #publichealth #AI @NYUAbuDhabi @pfizer
Amrit Ray retweeted
Around the 🌎, the toll of #NCDs is unprecedented; they pose a crisis for patients, #publichealth & societies: https://teapawt.net/t.co/0QjtcJJBEN @NCDAlliance #UNGA
Amrit Ray retweeted
Benefits & risks of innovation in clinical trials. Great discussion by John Alexander, Roger Lewis & Ted Lystig. Make sure you read to the bottom of Roger’s slide. @CTTI_Trials
Amrit Ray retweeted
The most undervalued professionals on the healthcare team is the #pharmacist. How they helped drive adherence for some of our sickest patients.
hbr.org/2019/01/how-pharmaci… – at Cerritos, CA
Amrit Ray retweeted
#RareDiseaseDay2019
#RareDiseaseDay is the official awareness-raising campaign for rare diseases. The objective is to raise awareness among the general public/decision-makers about #rarediseases & their impact on patients' lives. See campaign materials: https://teapawt.net/t.co/CN9hzCbERw
Amrit Ray retweeted
What's on the horizon for bioethics? We've created an infographic of developments in biology and medicine that might engage and challenge public interest and public values. @hudge44 explains more about it in his latest blog post nuffieldbioethics.org/blog/s…


























